Taproot Management LP
Source: SEC Form 13F · as of Mar 2026Taproot Management LP holds 24 biotech & pharma companies tracked by BioSniper, totaling $85.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
24
Total value held
$85.5M
| Company | Shares | Value |
|---|---|---|
| WSTWest Pharmaceutical Services Inc. | 43,673 | $10.9M |
| ELVElevance Health Inc. | 32,111 | $9.4M |
| ABBVAbbVie Inc. | 36,080 | $7.8M |
| ABTABBOTT LABORATORIES | 70,425 | $7.2M |
| RPRXRoyalty Pharma plc | 129,592 | $6.2M |
| PFEPFIZER INC | 192,873 | $5.4M |
| ZBHZimmer Biomet Holdings Inc. | 51,622 | $4.7M |
| MEDPMedpace Holdings Inc. | 7,819 | $3.8M |
| CORCencora Inc. | 11,306 | $3.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 12,612 | $3.4M |
| RGENREPLIGEN CORP | 27,125 | $3.2M |
| IQVIQVIA Holdings Inc. | 18,208 | $3.1M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 49,345 | $2.8M |
| DVADaVita Inc. | 12,610 | $1.9M |
| ALHCAlignment Healthcare Inc. | 106,582 | $1.9M |
| IDXXIDEXX LABORATORIES INC /DE | 3,321 | $1.9M |
| CAHCardinal Health Inc. | 8,195 | $1.7M |
| NVONovo Nordisk A/S | 35,558 | $1.3M |
| LLYELI LILLY & Co | 1,346 | $1.2M |
| ARGXARGENX SE | 1,674 | $1.2M |
| INCYIncyte Corp. | 10,751 | $1.0M |
| BIIBBIOGEN INC. | 5,133 | $941K |
| TECHBIO-TECHNE Corp | 7,995 | $418K |
| OSCROscar Health Inc. | 34,814 | $399K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.